Pérez-Neri I, Diéguez-Campa CE, Tadger P, Sandova H, Castillo-García VL, Kumar SA, Carneiro CCA, Chaurasia B, Uy EJB, Ríos C

Idioma: Ingles.
Referencias bibliográficas: 42
Paginas: 27-34
Archivo PDF: 200.31 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, FajarJK, Frediansyah A, Syahrul FN, Imran I, Haris S, Rambe AS, Emran TB,Rabaan AA, Tiwari R, Dhama K, Nainu F, Mutiawati E, Harapan H.Hemorrhagic and ischemic stroke in patients with coronavirus disease

2. 2019: incidence, risk factors, and pathogenesis - a systematic reviewand meta-analysis. F1000Research. 2021;10:34.2. Bhatti AUR, Zreik J, Yolcu YU, Alvi MA, Abode-Iyamah K, Quinones-Hinojosa A, Bydon M. Nervous System Involvement in SARS-Coronavirusinfection: A Review on Lessons Learned from the Previous Outbreaks,Ongoing Pandemic and What to Expect in the Future. Int J Neurosci.2021

3. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. PresumedAsymptomatic Carrier Transmission of COVID-19. JAMA. 2020

4. AHA/ASA SCL. Temporary Emergency Guidance to US Stroke CentersDuring the Coronavirus Disease 2019 (COVID-19) Pandemic: OnBehalf of the American Heart Association/American Stroke AssociationStroke Council Leadership. Stroke. 2020;51(6):1910-1912.

5. Antony J, James WT, Neriamparambil AJ, Barot DD, Withers T. AnAustralian Response to the COVID-19 Pandemic and Its Implications onthe Practice of Neurosurgery. World Neurosurgery. 2020

6. Babik JM, Fung M. COVID-19 in Immunocompromised Hosts: What WeKnow So Far. 2020

7. Wang F, Kream RM, Stefano GB. Long-Term Respiratory and NeurologicalSequelae of COVID-19. Med Sci Monit. 2020;26:e9289996.

8. Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact ofcerebrovascular and cardiovascular diseases on mortality and severityof COVID-19-systematic review, meta-analysis, and meta-regression. JStroke Cerebrovasc Dis. 2020;29(8):104949.

9. Parsay S, Vosoughi A, Khabbaz A, Sadigh-Eteghad S. The Incidence andMortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19Cases: A Systematic Review and Meta-Analysis. Journal of Stroke andCerebrovascular Diseases. 2021;30(3):105552.

10. Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, SabooryE. Neurological manifestations of Coronavirus Infections: Role ofAngiotensin-Converting Enzyme 2 in COVID-19. Int J Neurosci.20201-11.

11. Chou SH-Y, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V,Mainali S, Bassetti C, Suarez JI, McNett M, Nolan L, Temro K, Cervantes-Arslanian AM, Anand P, Mukerji S, Alabasi H, Westover MB, Kavi T, JohnS, Da Silva I, Shaik A, Sarwal A, Izzy S, Liotta EM, Batra A, Aysenne A,Rubinos C, Azzam AY, Azab MA, Sandall J, Persondek LM, Ulmer H,Rass V, Pfausler B, Müller C, Jung S, Crean M, Meoni S, Bereczki D,Kovács T, Agajany N, Armon C, Wolfson S, Cotelli MS, BianchiE, Riahi A, Öztürk S, Ural O, Viktoriia G, Lesiv M, Maia L, OliveiraV, Seabra M, Carvalho V, Vespa P, Provencio J, Olson D, Hemphill C,Venkatasubba Rao CP, Ko N, Fink E, Robertson C, Schober M, SmithScott A, Hammond M, Paul N, Safonova A, Kaplan L, Ratnayake C,Sharma AD, Skeel A, Villamizar Rosales C, Dolak D, Varelas P, LotmanL, Kaltenbach L, David K. M, GCS-NeuroCOVID CAENERGYC. GlobalIncidence of Neurological Manifestations Among Patients HospitalizedWith COVID-19—A Report for the GCS-NeuroCOVID Consortium andthe ENERGY Consortium. JAMA Network Open. 2021;4(5):e2112131.

12. Al-Olama M, Rashid A, Garozzo D. COVID-19-associatedmeningoencephalitis complicated with intracranial hemorrhage: a casereport. Acta Neurochir (Wien). 2020

13. De Luca P, Camaioni A, Marra P, Salzano G, Carriere G, Ricciardi L, PucciR, Montemurro N, Brenner MJ, Di Stadio A. Effect of Ultra-MicronizedPalmitoylethanolamide and Luteolin on Olfaction and Memory inPatients with Long COVID: Results of a Longitudinal Study. Cells.2022;11(16):2552.

14. Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants ofthe severity of COVID-19: A systematic review and meta-analysis. PLoSOne. 2021;16(5):e0250602.

15. Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N.Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathologyand Risk Morbidities. Neurol Int. 2022;14(2):391-405.

16. Wang Y, Shi L, Wang Y, Duan G, Yang H. Cerebrovascular disease isassociated with the risk of mortality in coronavirus disease 2019.[letter].Neurol Sci 2020;41(8):2017-2019.

17. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease isassociated with an increased disease severity in patients with CoronavirusDisease 2019 (COVID-19): A pooled analysis of published literature.International Journal of Stroke. 2020;15(4):385-389.

18. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology:a systematic review. Stroke. 2009;40(4):1082-1090.

19. Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: Asystematic review and meta-analysis. Int J Stroke. 2021;16(2):137-149.

20. Rosca EC, Tudor R, Cornea A, Simu M. Parkinson’s Disease in Romania:A Scoping Review Protocol. Brain Sci. 2021;11(2):251.

21. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, MulrowCD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J,Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E,McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, WelchVA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration:updated guidance and exemplars for reporting systematic reviews. BMJ.2021;372:n160.

22. Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I,Gøtzsche PC, Lasserson T, Tovey D, PRISMA FAG. PRISMA for Abstracts:reporting systematic reviews in journal and conference abstracts. PLoSMed. 2013;10(4):e1001419.

23. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, PetticrewM, Shekelle P, Stewart LA, PRISMA-P G. Preferred reporting items forsystematic review and meta-analysis protocols (PRISMA-P) 2015:elaboration and explanation. BMJ. 2015;350:g7647.

24. Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C,Kamel C, Affengruber L, Stevens A. Cochrane Rapid Reviews MethodsGroup offers evidence-informed guidance to conduct rapid reviews. JClin Epidemiol. 2021;130:13-22.

25. Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI;2020

26. Stroup DF. Meta-analysis of Observational Studies inEpidemiologyA Proposal for Reporting

27. Polhemus AM, Bergquist R, Bosch de Basea M, Brittain G, Buttery SC,Chynkiamis N, Dalla Costa G, Delgado Ortiz L, Demeyer H, EmmertK, Garcia Aymerich J, Gassner H, Hansen C, Hopkinson N, KluckenJ, Kluge F, Koch S, Leocani L, Maetzler W, Micó-Amigo ME, MikolaizakAS, Piraino P, Salis F, Schlenstedt C, Schwickert L, Scott K, SharrackB, Taraldsen K, Troosters T, Vereijken B, Vogiatzis I, Yarnall A, MazzaC, Becker C, Rochester L, Puhan MA, Frei A. Walking-related digitalmobility outcomes as clinical trial endpoint measures: protocol for ascoping review. BMJ Open. 2020;10(7):e038704.

28. Strech D, Synofzik M, Marckmann G. Systematic reviews of empiricalbioethics. J Med Ethics. 2008;34(6):472-477.

29. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodologicalguidance for systematic reviews of observational epidemiological studiesreporting prevalence and cumulative incidence data. Int J Evid BasedHealthc. 2015;13(3):147-153.

30. Booth A, Sutton A, Papaioannou D. Systematic approaches to asuccessful literature review. Sage; 2016

31. Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, PageMJ, Koffel JB, PRISMA-S G. PRISMA-S: an extension to the PRISMAStatement for Reporting Literature Searches in Systematic Reviews. SystRev. 2021;10(1):39.

32. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V,Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015Guideline Statement. J Clin Epidemiol. 2016;75:40-46.

33. Feng Y, Luo W, Ma J, L T. A coagulation marker in patients with severecoronavirus disease 2019 (COVID-19): a meta-analysis. PROSPEROCRD42020179519. 2020

34. McKeown S, Mir ZM. Considerations for conducting systematic reviews:evaluating the performance of different methods for de-duplicatingreferences. Syst Rev. 2021;10(1):38.

35. Bozada T, Borden J, Workman J, Del Cid M, Malinowski J, LuechtefeldT. Sysrev: A FAIR Platform for Data Curation and Systematic EvidenceReview. Front Artif Intell. 2021;4:685298.

36. Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020:An R package and Shiny app for producing PRISMA 2020-compliantflow diagrams, with interactivity for optimised digital transparency andOpen Synthesis. Campbell Systematic Reviews. 2022;18(2)

37. Papadopoulos VP, Koutroulos M-V, Zikoudi D-G, Bakola S-A, AvramidouP, Touzlatzi N, Filippou DK. Acute Metabolic Emergencies in Diabetesand COVID-19: a systematic review and meta-analysis of case reports.medRxiv. 2021

38. Usher R, Stapleton T. Approaches for assessing decision-making capacityin older adults: a scoping review protocol. JBI Evidence Synthesis.2020;18(4):832-840.

39. Barges-Coll J, Pérez-Neri I, Avendaño J, Mendez-Rosito D, Gomez-Amador JL, Ríos C. Plasma taurine as a predictor of poor outcome inpatients with mild neurological deficits after aneurysmal subarachnoidhemorrhage. J Neurosurg. 2013;119(4):1021-1027.

40. Medeiros P, Bailey C, Andrews C, Liley H, Pollock D, Gordon A, FlenadyV. Effectiveness of neonatal “near miss” audits in reducing perinatalmorbidity and mortality. JBI Evidence Synthesis. 2021;Publish Ahead ofPrint

41. Yammine K, Otayek J, Assi C. Evidence-based conservative limbpreserving surgery for the diabetic foot complications: A systematic reviewof systematic reviews. Foot Ankle Surg. 2021S1268-7731(21)00177.

42. Verde PE. A bias-corrected meta-analysis model for combining, studiesof different types and quality. Biometrical Journal. 2021;63(2):406-422.